vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and SHOE CARNIVAL INC (SCVL). Click either name above to swap in a different company.

SHOE CARNIVAL INC is the larger business by last-quarter revenue ($297.2M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). SHOE CARNIVAL INC runs the higher net margin — 4.9% vs 0.7%, a 4.2% gap on every dollar of revenue. On growth, SHOE CARNIVAL INC posted the faster year-over-year revenue change (-3.2% vs -16.5%). SHOE CARNIVAL INC produced more free cash flow last quarter ($19.7M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Shoe Carnival Inc. is an American retailer of family footwear. The company operates 429 stores throughout the midwest, south, and southeast regions, and Puerto Rico. It was founded by David Russell in 1978 and is headquartered in Fort Mill, South Carolina as of 2025.

HCM vs SCVL — Head-to-Head

Bigger by revenue
SCVL
SCVL
1.1× larger
SCVL
$297.2M
$270.8M
HCM
Growing faster (revenue YoY)
SCVL
SCVL
+13.4% gap
SCVL
-3.2%
-16.5%
HCM
Higher net margin
SCVL
SCVL
4.2% more per $
SCVL
4.9%
0.7%
HCM
More free cash flow
SCVL
SCVL
$16.4M more FCF
SCVL
$19.7M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HCM
HCM
SCVL
SCVL
Revenue
$270.8M
$297.2M
Net Profit
$2.0M
$14.6M
Gross Margin
37.7%
37.6%
Operating Margin
-13.2%
6.3%
Net Margin
0.7%
4.9%
Revenue YoY
-16.5%
-3.2%
Net Profit YoY
-83.6%
-23.9%
EPS (diluted)
$0.00
$0.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SCVL
SCVL
Q4 25
$270.8M
$297.2M
Q3 25
$306.4M
Q2 25
$277.7M
$277.7M
Q1 25
$324.5M
$262.9M
Q4 24
$306.9M
Q3 24
$332.7M
Q2 24
$305.7M
$300.4M
Q1 24
$280.2M
Net Profit
HCM
HCM
SCVL
SCVL
Q4 25
$2.0M
$14.6M
Q3 25
$19.2M
Q2 25
$455.0M
$9.3M
Q1 25
$11.9M
$14.7M
Q4 24
$19.2M
Q3 24
$22.6M
Q2 24
$25.8M
$17.3M
Q1 24
$15.5M
Gross Margin
HCM
HCM
SCVL
SCVL
Q4 25
37.7%
37.6%
Q3 25
38.8%
Q2 25
0.1%
34.5%
Q1 25
48.0%
34.9%
Q4 24
36.0%
Q3 24
36.1%
Q2 24
41.1%
35.6%
Q1 24
35.6%
Operating Margin
HCM
HCM
SCVL
SCVL
Q4 25
-13.2%
6.3%
Q3 25
8.2%
Q2 25
-1.3%
4.3%
Q1 25
-5.0%
5.3%
Q4 24
8.0%
Q3 24
9.0%
Q2 24
-9.0%
7.5%
Q1 24
7.1%
Net Margin
HCM
HCM
SCVL
SCVL
Q4 25
0.7%
4.9%
Q3 25
6.3%
Q2 25
163.8%
3.4%
Q1 25
3.7%
5.6%
Q4 24
6.3%
Q3 24
6.8%
Q2 24
8.4%
5.8%
Q1 24
5.5%
EPS (diluted)
HCM
HCM
SCVL
SCVL
Q4 25
$0.00
$0.53
Q3 25
$0.70
Q2 25
$0.52
$0.34
Q1 25
$0.01
$0.53
Q4 24
$0.70
Q3 24
$0.82
Q2 24
$0.03
$0.63
Q1 24
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SCVL
SCVL
Cash + ST InvestmentsLiquidity on hand
$1.4B
$107.7M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$683.2M
Total Assets
$1.8B
$1.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SCVL
SCVL
Q4 25
$1.4B
$107.7M
Q3 25
$91.9M
Q2 25
$1.4B
$93.0M
Q1 25
$836.1M
$123.1M
Q4 24
$91.1M
Q3 24
$84.5M
Q2 24
$802.5M
$69.5M
Q1 24
$111.2M
Total Debt
HCM
HCM
SCVL
SCVL
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
SCVL
SCVL
Q4 25
$1.2B
$683.2M
Q3 25
$670.7M
Q2 25
$1.2B
$653.6M
Q1 25
$759.9M
$649.0M
Q4 24
$635.7M
Q3 24
$618.5M
Q2 24
$740.1M
$597.8M
Q1 24
$583.4M
Total Assets
HCM
HCM
SCVL
SCVL
Q4 25
$1.8B
$1.2B
Q3 25
$1.2B
Q2 25
$1.8B
$1.1B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.0B
Debt / Equity
HCM
HCM
SCVL
SCVL
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SCVL
SCVL
Operating Cash FlowLast quarter
$8.2M
$33.6M
Free Cash FlowOCF − Capex
$3.4M
$19.7M
FCF MarginFCF / Revenue
1.2%
6.6%
Capex IntensityCapex / Revenue
1.8%
4.7%
Cash ConversionOCF / Net Profit
4.21×
2.30×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$35.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SCVL
SCVL
Q4 25
$8.2M
$33.6M
Q3 25
$13.3M
Q2 25
$-72.9M
$-9.6M
Q1 25
$40.3M
$44.5M
Q4 24
$17.3M
Q3 24
$23.7M
Q2 24
$-39.8M
$17.1M
Q1 24
$53.4M
Free Cash Flow
HCM
HCM
SCVL
SCVL
Q4 25
$3.4M
$19.7M
Q3 25
$2.2M
Q2 25
$-82.2M
$-23.0M
Q1 25
$32.5M
$36.2M
Q4 24
$8.3M
Q3 24
$18.2M
Q2 24
$-49.9M
$6.9M
Q1 24
$40.7M
FCF Margin
HCM
HCM
SCVL
SCVL
Q4 25
1.2%
6.6%
Q3 25
0.7%
Q2 25
-29.6%
-8.3%
Q1 25
10.0%
13.8%
Q4 24
2.7%
Q3 24
5.5%
Q2 24
-16.3%
2.3%
Q1 24
14.5%
Capex Intensity
HCM
HCM
SCVL
SCVL
Q4 25
1.8%
4.7%
Q3 25
3.6%
Q2 25
3.3%
4.8%
Q1 25
2.4%
3.2%
Q4 24
3.0%
Q3 24
1.7%
Q2 24
3.3%
3.4%
Q1 24
4.5%
Cash Conversion
HCM
HCM
SCVL
SCVL
Q4 25
4.21×
2.30×
Q3 25
0.69×
Q2 25
-0.16×
-1.03×
Q1 25
3.38×
3.04×
Q4 24
0.90×
Q3 24
1.05×
Q2 24
-1.54×
0.99×
Q1 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons